Transparency List AVWG

Drug price comparison Germany

The Transparency List AVWG in a nutshell

The Transparency List AVWG (AVWG Arzneimittelversorgungs Wirtschaftlichkeitsgesetz) compares prices of original, generics and reimported products, Bonus Malus aspects of the AVWG are considered with their effects on:

  • Refunds by the GKVen
  • Payments and co-payments by the patient
  • Discount of the manufacturers
  • Discounts from pharmacies

The tabular overviews are supplemented by compact economic-pharmaceutical information on the listed medicinal products.

The focus of the transparency list is deliberately on the economic aspects of drug therapy. It does not refer to clinical aspects of the substitution of original preparations.

How up-to-date is the data?

The update of the latest economic changes in the German market is every 14 days.

WHERE DOES THE INFORMATION COME FROM?

This tool´s data is based on the database Drug Pricing Tool Germany in [pharmazie.com]. This database is updated twice a month. For you, this involves: reliability, seriousness and safety.

R

Suitable for:

Pharma Industry, Pharma Trade, Health Insurance, Regulatory

Source: AVOXA ABDATA

Eschborn, Germany

Related subscription

This database can be accessed after purchasing the subscription package ‘Drug Pricing’ or ‘Premium’

Related posts

Estimating the final price of a prescription-only product

Estimating the final price of a prescription-only product At a glance: Pricing for pharmaceuticals in Germany Supply and demand determine the price, at least considering most branches of a free market economy. This basic principle also applies to non-prescription...

Drug Pricing Germany Database ABDA Artikelstamm Taxe

Drug Pricing Tool German Medicinal Products - ABDA-Artikelstamm (Taxe)The Drug Pricing Tool German Medicinal Products - ABDA-Artikelstamm (Taxe) includes all economic data for all drugs sold in pharmacies in Germany. Pressed to make pricing decisions? Need to...

We are here for you

Any left questions?

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and drug information from our team.

You have Successfully Subscribed!